ESR1 and breast carcinoma: This is especially critical in the histologically identified hormone receptor positive (HR+) breast cancer subtype, which accounts for approximately ~70% of breast cancer cases and relies on the estrogen receptor alpha (ER) for proliferation and tumor growth [2].